cellcept
roche registration gmbh - mikofenolat mofetil - odbacivanje transplantata - imunosupresivi - cellcept je indiciran u kombinaciji sa ciklosporin i kortikosteroidi za profilaksa akutnog transplantaciju odbacivanja u bolesnika koji su primali alogene transplantacije bubrega, srca ili jetre.
cellcept 500mg film tableta
"hoffmann-la roche ltd" d.s.d. podgorica - mikofenolna kiselina - film tableta - 500mg
cellcept 250mg kapsula, tvrda
"hoffmann-la roche ltd" d.s.d. podgorica - mikofenolna kiselina - kapsula, tvrda - 250mg
sclefic 50 mg/1 tableta film tableta
pliva d.o.o.sarajevo - riluzol - film tableta - 50 mg/1 tableta - 1 film tableta sadrži: 50 mg riluzol
jayempi
nova laboratories ireland limited - azathioprine - odbacivanje transplantata - imunosupresivi - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.
seroxat 20 mg/1 tableta filmom obložena tableta
evropa lijek pharma d.o.o. - paroksetin - filmom obložena tableta - 20 mg/1 tableta - 1 filmom obložena tableta sadrži: 20 mg paroksetina (u obliku paroksetinhidrohlorid, hemihidrata)
lamictal 2 mg/1 tableta tableta za žvakanje
glaxosmithkline d.o.o.sarajevo - lamotrigin - tableta za žvakanje - 2 mg/1 tableta - jedna tableta za žvakanje sadrži: 2 mg lamotrigina
zinnat 125 mg/1 tableta filmom obložena tableta
evropa lijek pharma d.o.o. - cefuroksim - filmom obložena tableta - 125 mg/1 tableta - 1 filmom obložena tableta sadrži: 125 mg cefuroksima (u obliku cefuroksim aksetila)
zinnat 250 mg/1 tableta filmom obložena tableta
evropa lijek pharma d.o.o. - cefuroksim - filmom obložena tableta - 250 mg/1 tableta - 1 filmom obložena tableta sadrži: 250 mg cefuroksima (u obliku cefuroksim aksetila)
zinnat 500 mg/1 tableta filmom obložena tableta
evropa lijek pharma d.o.o. - cefuroksim - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži: 500 mg cefuroksima (u obliku cefuroksim aksetila)